Complete pathological response after neoadjuvant therapy in patients with rectal adenocarcinoma

Background: Colorectal cancer is the fourth most common cancer and the second leading cause of death from cancer in the United States. Preoperative neoadjuvant therapy (chemotherapy and radiotherapy) is the gold standard in the management of rectal cancer before surgical resection. The literature in...

Full description

Bibliographic Details
Main Authors: E.A. Sánchez-Pérez, J.A. Villanueva-Herrero, M.D. Sandoval-Martínez, B. Jiménez-Bobadilla
Format: Article
Language:English
Published: Permanyer 2017-10-01
Series:Revista Médica del Hospital General de México
Online Access:http://www.sciencedirect.com/science/article/pii/S0185106317300513